Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 36,958 shares at $107.40 ($4.0M) on 2016-11-22, disclosed to the SEC on 2016-11-25.
Open-market sale of $4.0M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.40 | 15,001 | $1.6M | 40.6% |
| 2 | $107.40 | 15,001 | $1.6M | 40.6% |
| 3 | $106.96 | 3,478 | $372K | 9.4% |
| 4 | $106.96 | 3,478 | $372K | 9.4% |
| Total | $107.32 avg | 36,958 | $4.0M | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |